These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 6378444)

  • 21. Gastric damage by drugs and the role of the mucosal barrier.
    Cooke AR
    Aust N Z J Med; 1976; 6 Suppl 1():Suppl 1:26-32. PubMed ID: 1087879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptic ulcer--current status.
    Brooks FP
    Clin Invest Med; 1987 May; 10(3):108-16. PubMed ID: 3113795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the risk factors and their combinations in acute gastroduodenal ulcer bleeding: a case-control study.
    Udd M; Miettinen P; Palmu A; Heikkinen M; Janatuinen E; Pasanen P; Tarvainen R; Mustonen H; Julkunen R
    Scand J Gastroenterol; 2007 Dec; 42(12):1395-403. PubMed ID: 17994466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of NSAID-related gastroduodenal mucosal injury.
    Aalykke C; Lauritsen K
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):705-22. PubMed ID: 11566036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of sucralfate in preventing peptic ulceration induced by nonsteroidal anti-inflammatory drugs.
    Hardin CK; Sexton CR; Peoples JB
    Am Surg; 1987 Jul; 53(7):373-6. PubMed ID: 3605853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-steroidal anti-inflammatory drugs and gastrointestinal bleeding.
    Lanas A
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S37-42. PubMed ID: 10379468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gastric mucosa barrier and the effect of non-steroidal anti-inflammatory agents and corticosteroid hormones on the gastric and duodenal mucosa].
    Daskalov A; Chernev K
    Vutr Boles; 1988; 27(3):13-7. PubMed ID: 3061174
    [No Abstract]   [Full Text] [Related]  

  • 28. Helicobacter pylori eradication may reduce the risk of gastroduodenal lesions in chronic NSAID users.
    Russell RI
    Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):465-9. PubMed ID: 9494858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Substances harmful for the gastric mucosa].
    Ponce J; Bixquert M; Hinojosa J; Garrigues V
    An Med Interna; 1991 Oct; 8(10):506-12. PubMed ID: 1751693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defining patients at risk of non-steroidal anti-inflammatory drug gastropathy.
    Russell RI
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S14-8. PubMed ID: 10379464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
    Scarpignato C; Pelosini I
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S63-72. PubMed ID: 10379472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology of peptic ulcer disease.
    Kurata JH; Haile BM
    Clin Gastroenterol; 1984 May; 13(2):289-307. PubMed ID: 6378441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of some antirheumatic agents on the gastric mucous membrane].
    Vasilenko VKh; Tsodikov GV; Minushkin ON
    Klin Med (Mosk); 1971 Aug; 49(8):3-10. PubMed ID: 4331391
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of ibuprofen lysinate and acetylsalicylic acid on gastric and duodenal mucosa. Randomized single-blind placebo-controlled endoscopic study in healthy volunteers.
    Müller P; Simon B
    Arzneimittelforschung; 1994 Jul; 44(7):840-3. PubMed ID: 7945519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage.
    Wilcox CM; Shalek KA; Cotsonis G
    Arch Intern Med; 1994 Jan; 154(1):42-6. PubMed ID: 8267488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Accumulation of risk factors before acute gastroduodenal hemorrhage: analgesic/antirheumatic drugs, alcohol and ulcer anamnesis].
    Eberle F; Rettenmaier G
    Z Gastroenterol; 1985 Mar; 23(3):107-14. PubMed ID: 4082688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute NSAID-related transmural duodenitis and extensive duodenal ulceration.
    Hashash JG; Atweh LA; Saliba T; Chakhachiro Z; Al-Kutoubi A; Tawil A; Barada KA
    Clin Ther; 2007 Nov; 29(11):2448-52. PubMed ID: 18158085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of the mucosal barrier in drug-induced gastric ulceration and erosions.
    Cooke AR
    Am J Dig Dis; 1976 Feb; 21(2):155-64. PubMed ID: 775970
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.